X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs DR. REDDYS LAB - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE DR. REDDYS LAB CADILA HEALTHCARE/
DR. REDDYS LAB
 
P/E (TTM) x 13.7 22.2 61.7% View Chart
P/BV x 2.9 3.4 85.0% View Chart
Dividend Yield % 1.4 0.8 182.9%  

Financials

 CADILA HEALTHCARE   DR. REDDYS LAB
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
DR. REDDYS LAB
Mar-18
CADILA HEALTHCARE/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs5582,788 20.0%   
Low Rs3621,902 19.0%   
Sales per share (Unadj.) Rs116.3860.8 13.5%  
Earnings per share (Unadj.) Rs17.957.1 31.3%  
Cash flow per share (Unadj.) Rs23.1122.0 19.0%  
Dividends per share (Unadj.) Rs3.5020.00 17.5%  
Dividend yield (eoy) %0.80.9 89.3%  
Book value per share (Unadj.) Rs85.4757.7 11.3%  
Shares outstanding (eoy) m1,023.74165.91 617.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.02.7 145.1%   
Avg P/E ratio x25.741.1 62.6%  
P/CF ratio (eoy) x19.919.2 103.4%  
Price / Book Value ratio x5.43.1 173.9%  
Dividend payout %19.635.0 55.9%   
Avg Mkt Cap Rs m470,664389,034 121.0%   
No. of employees `00011.823.5 50.2%   
Total wages/salary Rs m18,54532,149 57.7%   
Avg. sales/employee Rs Th10,072.76,070.8 165.9%   
Avg. wages/employee Rs Th1,569.11,366.6 114.8%   
Avg. net profit/employee Rs Th1,547.7402.5 384.5%   
INCOME DATA
Net Sales Rs m119,049142,810 83.4%  
Other income Rs m1,1321,552 72.9%   
Total revenues Rs m120,181144,362 83.2%   
Gross profit Rs m28,47523,512 121.1%  
Depreciation Rs m5,38810,772 50.0%   
Interest Rs m911788 115.6%   
Profit before tax Rs m23,30813,504 172.6%   
Minority Interest Rs m6280-   
Prior Period Items Rs m0344 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,6444,380 128.9%   
Profit after tax Rs m18,2929,468 193.2%  
Gross profit margin %23.916.5 145.3%  
Effective tax rate %24.232.4 74.7%   
Net profit margin %15.46.6 231.8%  
BALANCE SHEET DATA
Current assets Rs m82,005104,984 78.1%   
Current liabilities Rs m60,72068,938 88.1%   
Net working cap to sales %17.925.2 70.8%  
Current ratio x1.41.5 88.7%  
Inventory Days Days7374 98.4%  
Debtors Days Days98104 94.9%  
Net fixed assets Rs m83,703104,385 80.2%   
Share capital Rs m1,024830 123.4%   
"Free" reserves Rs m86,421124,886 69.2%   
Net worth Rs m87,445125,716 69.6%   
Long term debt Rs m25,55125,089 101.8%   
Total assets Rs m180,653225,443 80.1%  
Interest coverage x26.618.1 146.6%   
Debt to equity ratio x0.30.2 146.4%  
Sales to assets ratio x0.70.6 104.0%   
Return on assets %10.64.5 233.7%  
Return on equity %20.97.5 277.8%  
Return on capital %22.09.7 226.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42,68372,623 58.8%   
Fx outflow Rs m11,24218,916 59.4%   
Net fx Rs m31,44153,707 58.5%   
CASH FLOW
From Operations Rs m9,19318,030 51.0%  
From Investments Rs m-9,737-14,883 65.4%  
From Financial Activity Rs m515-4,440 -11.6%  
Net Cashflow Rs m-29-1,236 2.3%  

Share Holding

Indian Promoters % 74.8 25.5 293.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 5.4 153.7%  
FIIs % 5.9 35.3 16.7%  
ADR/GDR % 0.0 18.5 -  
Free float % 11.0 15.3 71.9%  
Shareholders   44,069 75,885 58.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   IPCA LABS  SANOFI INDIA  ALEMBIC PHARMA  ORCHID PHARMA LTD  NOVARTIS  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Jet Airways and Yes Bank - What's Next for these Beaten Down Stocks?(Podcast)

Jet Airways and Yes Bank, both once market darlings are now being shunned by market participants. The National Stock Exchange (NSE) exchange notified that the shares of the airline.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

More Views on News

Most Popular

The Best 4 Small-cap Stocks to Buy(The 5 Minute Wrapup)

Jun 3, 2019

In the sometimes good sometimes bad market of small caps, there are strong buying opportunities available today. But this great opportunity won't last forever.

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Top 7 Stocks to Profit from Modi's Repeat Performance(Profit Hunter)

Jun 3, 2019

The long-term India story looks promising with the Modi government back in power. Which stocks are likely to go up the most?

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jun 14, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS